Clinical management of polycystic kidney disease

Clinical Medicine

Volumn 3, Issue 6, 2003, Pages 509-512

  Hateboer, Nick ^a  

^a DORSET COUNTY HOSPITAL   (United Kingdom)

Author keywords

Autosound dominant; Polycystic kidney

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POLYCYSTIN;

AUTOSOMAL DOMINANT DISORDER; CLINICAL FEATURE; GENETIC COUNSELING; GENETIC SCREENING; HEART LEFT VENTRICLE HYPERTROPHY; HEMATURIA; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LINKAGE ANALYSIS; PAIN; REVIEW;

EID: 0346251187     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.3-6-509     Document Type: Review

References (16)

1. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell 1994;77:881-94.
2. Mochizuki T, Wu G, Hayashi T, Xenophontos SL et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272:1339-42.
3. Igarashi P, Somlo S. Genetics and pathogenesis of polycystic kidney disease. Review. J Am Soc Nephrol 2002;13:2384-98.
4. Hateboer N, van Dijk M, Bogdanova N, Coto E et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 1999;353:103-7.
5. Ravine D, Gibson RN, Walker RG, Sheffield LJ et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994;343:824-7.
6. Klahr S, Breyer JA, Beck GJ, Dennis VW et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J Am Soc Nephrol 1995;5:2037-47.
7. Fick GM, Johnson AM, Hammond WS, Gabow PA. Causes of death in autosomal dominant polycystic kidney disease. Review. J Am Soc Nephrol 1995;5:2048-56.
8. Schrier R, McFann K, Johnson A, Chapman A et al. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study. J Am Soc Nephrol 2002;13: 1733-9.
9. Taylor JE, Calne RY, Stewart WK. Massive cystic hepatomegaly in a female patient with polycystic disease treated by combined hepatic and renal transplantation. QJM QIM 1991;80:771-5.
10. Pirson Y, Chauveau D, Torres V. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. Review. J Am Soc Nephrol 2002;13:269-76.
11. Sharp CK, Zeligman BE, Johnson AM, Duley I, Gabow PA. Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease. Am J Kidney Dis 1999;34:863-8.
12. Stewart JH, Buccianti G, Agodoa L, Gellert R et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 2003;14:197-207.
13. Keith DS, Torres VE, King BF, Zincki H, Farrow GM. Renal cell carcinoma in autosomal dominant polycystic kidney disease. Review. J Am Soc Nephrol 1994;4:1661-9.
14. Davis ID, MacRae Dell K, Sweeney WE, Avner ED. Can progression of autosomal dominant or autosomal recessive polycystic kidney disease be prevented? Review. Semin Nephrol 2001;21:430-40.
15. Schrier RW, McFann KK, Johnson AM. Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int 2003;63:678-85.
16. Yoder BK, Hou X, Guay-Woodford LM. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris and cystin, are co-localized in renal cilia. J Am Soc Nephrol 2002;13:2508-16.